Effect of nanoencapsulated(-)- Epigallocatechin gallate on lipid accumulation and proliferation of mouse 3T3-L1 preadipocytes
Abstract
Green tea is known for its potential health benefits. These health benefits
are related mainly to their polyphenol content. Catechins are the major component
of the green tea polyphenols (Balentine, Wiseman, & Bouwens, 1997) Catechins
are the major source of flavonols and they are comprised of various types of
catechins such as epigallo catechin 3 gallate (EGCG), epigallocatechin (EGC),
epicatechin gallate (ECG) (Sano, et al., 2001). Many studies have reported and
demonstrated that EGCG can exert anti-obesity effects.
Obesity is considered the major risk factor for type 2 diabetes mellitus
(T2DM), cardio-vascular diseases like hypertension and atherosclerosis (Serrano
Rios, M., 1998 (Serrano Rios, 1998). Being slightly overweight can also lead to
the onset of life-style related health diseases (Wolfram, Wang, & Thielecke,
2006). Considering all the health related diseases linked to obesity, it can lead to
metabolic syndrome hence, prevention of obesity is gaining the major attention
over the treatment.
Number of studies demonstrated that EGCG can inhibit lipid accumulation
in adipocytes (Lee, Kim, & Kim, 2009). But, it has not been proved to reduce the
fat mass in humans and research animals. The major reason behind this problem is
the EGCG bio-availability which is very low in animals as well as in humans.
Along with the problem of bio-availability, another factor is instability of EGCG
and higher metabolic degradation. Therefore, to gain maximum benefit of this
biologically functional molecule, it is important to use biocompatible and
biodegradable nanoparticles in order to increase its stability and absorption
thereby, enhancing its bio-availability.
Nanotechnology is promising area which offers higher EGCG bio- availability and stability, at which EGCG can be used to exert its beneficial health
effects in reducing lipid accumulation.